LIVE | Pfizer and BioNTech provide volunteers who received placebo vaccine Inland

Follow the latest corona news in this live blog.

The American pharmaceutical company Pfizer and the German BioNTech give volunteers who received a placebo during the test phase of the vaccine the option to be eligible for the first dose of the vaccine from 1 March this year. They will then continue to be part of the investigation.

The so-called Vaccine Transition Option in the study allows trial participants aged 16 and older to find out whether they were given the vaccine or a placebo. For those who received a placebo, two doses of the study vaccine were reserved within the overall study, the companies report on the website.

“The research doctor will follow the latest guidelines from the US Centers for Disease Control and Prevention and local health organizations to provide priority participants with the Vaccine Transition Option,” the pharmaceutical company said.

More news:

Inland:

Abroad:

Financial-economic:

Sport:

Entertainment / personal:

View here yesterday’s live blog.

–